obesity drug news today glp-1 october 2025 Weight-Loss Demonstration Begins July 2026 obesity drug news today glp-1
Description
Blood pressure control was unaffected in the LEADER trial (N=9,340), where 82% of patients were on renin-angiotensin system inhibitors and no signal of hypertension worsening appeared [19]
Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans
For many people, this supports thinking of treatment as ongoing rather than short-term
How Much Weight Can You Expect to Lose with a GLP-1 program
A clinical trial found that in patients with MCI, a 32-week trial of slow-release exenatide had no beneficial effect on cognitive performance (Vadini et al., 2020)
Hair Loss Solutions for GLP-1 Users
